← Back to Search
Asbestos, Lung Cancers, And Mesotheliomas: From Molecular Approaches To Targeting Tumor Survival Pathways.
N. H. Heintz, Y. Janssen-Heininger, B. Mossman
Published 2010 · Biology, Medicine
Download PDFAnalyze on Scholarcy
Fifteen years have passed since we published findings in the AJRCMB demonstrating that induction of early response fos/jun proto-oncogenes in rodent tracheal and mesothelial cells correlates with fibrous geometry and pathogenicity of asbestos. Our study was the first to suggest that the aberrant induction of signaling responses by crocidolite asbestos and erionite, a fibrous zeolite mineral associated with the development of malignant mesotheliomas (MMs) in areas of Turkey, led to altered gene expression. New data questioned the widely held belief at that time that the carcinogenic effects of asbestos in the development of lung cancer and MM were due to genotoxic or mutagenic effects. Later studies by our group revealed that proto-oncogene expression and several of the signaling pathways activated by asbestos were redox dependent, explaining why antioxidants and antioxidant enzymes were elevated in lung and pleura after exposure to asbestos and how they alleviated many of the phenotypic and functional effects of asbestos in vitro or after inhalation. Since these original studies, our efforts have expanded to understand the interface between asbestos-induced redox-dependent signal transduction cascades, the relationship between these pathways and cell fate, and the role of asbestos and cell interactions in development of asbestos-associated diseases. Of considerable significance is the fact that the signal transduction pathways activated by asbestos are also important in survival and chemoresistance of MMs and lung cancers. An understanding of the pathogenic features of asbestos fibers and dysregulation of signaling pathways allows strategies for the prevention and therapy of asbestos-related diseases.
This paper references
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Catherine Dostert (2008)
Induction of c-fos and c-jun proto-oncogenes in target cells of the lung and pleura by carcinogenic fibers.
Y. Janssen (1994)
A mutant epidermal growth factor receptor targeted to lung epithelium inhibits asbestos-induced proliferation and proto-oncogene expression.
Christopher B Manning (2002)
Expression of antioxidant enzymes in rat lungs after inhalation of asbestos or silica.
Y. Janssen (1992)
Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.
B. Fuchs (2008)
Transcriptional activation of the proto-oncogene c-jun by asbestos and H2O2 is directly related to increased proliferation and transformation of tracheal epithelial cells.
C. Timblin (1995)
IL‐1, IL‐18, and IL‐33 families of cytokines
W. Arend (2008)
Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein
K. Katayama (2007)
Integrin-linked kinase (ILK): a "hot" therapeutic target.
T. N. Yoganathan (2000)
Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases.
A. Shukla (2003)
P53 mediates amosite asbestos-induced alveolar epithelial cell mitochondria-regulated apoptosis.
V. Panduri (2006)
Different accumulation of activated extracellular signal-regulated kinases (ERK 1/2) and role in cell-cycle alterations by epidermal growth factor, hydrogen peroxide, or asbestos in pulmonary epithelial cells.
S. Buder-Hoffmann (2001)
Increased expression of epidermal growth factor receptor in rat pleural mesothelial cells correlates with carcinogenicity of mineral fibres.
S. Faux (2000)
Novel cell imaging techniques show induction of apoptosis and proliferation in mesothelial cells by asbestos.
J. Goldberg (1997)
Persistent localization of activated extracellular signal-regulated kinases (ERK1/2) is epithelial cell-specific in an inhalation model of asbestosis.
A. Cummins (2003)
Advances in malignant mesothelioma.
B. Robinson (2005)
Persistent induction of c-fos and c-jun expression by asbestos.
N. H. Heintz (1993)
Vitronectin adsorption to chrysotile asbestos increases fiber phagocytosis and toxicity for mesothelial cells.
J. Wu (2000)
Asbestos: scientific developments and implications for public policy.
B. Mossman (1990)
Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family.
H. Shepard (2008)
Oxidant stress responses in human pleural mesothelial cells exposed to asbestos.
Y. Janssen (1994)
Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor.
C. Zanella (1996)
Fra-1 governs cell migration via modulation of CD44 expression in human mesotheliomas
Maria E. Ramos-Nino (2007)
Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibers.
J. Pache (1998)
A protein kinase Cdelta-dependent protein kinase D pathway modulates ERK1/2 and JNK1/2 phosphorylation and Bim-associated apoptosis by asbestos.
S. Buder-Hoffmann (2009)
EPIDERMAL GROWTH FACTOR-MEDIATED ACTIVATION OF THE MAP KINASE CASCADE RESULTS IN ALTERED EXPRESSION AND FUNCTION OF ABCG2 (BCRP)
Henriette E. Meyer zu Schwabedissen (2006)
Human mesothelioma cells exhibit tumor cell–specific differences in phosphatidylinositol 3-kinase/AKT activity that predict the efficacy of Onconase
Maria E. Ramos-Nino (2005)
Role of alphavbeta5 integrin receptor in endocytosis of crocidolite and its effect on intracellular glutathione levels in human lung epithelial (A549) cells.
P. Pande (2006)
Asbestos induces mitochondrial DNA damage and dysfunction linked to the development of apoptosis.
A. Shukla (2003)
Transfection of a manganese-containing superoxide dismutase gene into hamster tracheal epithelial cells ameliorates asbestos-mediated cytotoxicity.
B. Mossman (1996)
Detection of 8-oxo-2'-deoxyguanosine, a marker of oxidative DNA damage, in culture medium from human mesothelial cells exposed to crocidolite asbestos.
Q. Chen (1996)
Cooperativity between Oxidants and Tumor Necrosis Factor in the Activation of Nuclear Factor (NF)- κ B
Y. Janssen-Heininger (1999)
Iron and reactive oxygen species in the asbestos-induced tumor necrosis factor-alpha response from alveolar macrophages.
P. Simeonova (1995)
Hydrolysis of inositol phospholipids precedes cellular proliferation in asbestos-stimulated tracheobronchial epithelial cells.
A. Sesko (1990)
Factors predicting response to EGFR tyrosine kinase inhibitors.
J. Engelman (2005)
Asbestos-induced phosphorylation of epidermal growth factor receptor is linked to c-fos and apoptosis.
C. Zanella (1999)
Alterations in gene expression in human mesothelial cells correlate with mineral pathogenicity.
A. Shukla (2009)
Integrin-induced Epidermal Growth Factor (EGF) Receptor Activation Requires c-Src and p130Cas and Leads to Phosphorylation of Specific EGF Receptor Tyrosines*
L. Moro (2002)
B. Mossman (1989)
Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent In vivo Activity in Mesothelioma
A. Sartore-Bianchi (2007)
The Duration of Nuclear Extracellular Signal-Regulated Kinase 1 and 2 Signaling during Cell Cycle Reentry Distinguishes Proliferation from Apoptosis in Response to Asbestos
Z. Yuan (2004)
Src-dependent ERK5 and Src/EGFR-dependent ERK1/2 activation is required for cell proliferation by asbestos
L. Scapoli (2004)
Increased manganese superoxide dismutase protein in type II epithelial cells of rat lungs after inhalation of crocidolite asbestos or cristobalite silica.
J. A. Holley (1992)
Induction of c-fos and c-jun proto-oncogene expression by asbestos is ameliorated by N-acetyl-L-cysteine in mesothelial cells.
Y. Janssen (1995)
Increased phosphorylated extracellular signal-regulated kinase immunoreactivity associated with proliferative and morphologic lung alterations after chrysotile asbestos inhalation in mice.
R. Robledo (2000)
Phosphorylated Extracellular Signal-regulated Kinases Are Significantly Increased in Malignant Mesothelioma
Merivane de Melo (2006)
Antivascular therapy of human follicular thyroid cancer experimental bone metastasis by blockade of epidermal growth factor receptor and vascular growth factor receptor phosphorylation.
M. Younes (2005)
Targeting the MEK1 cascade in lung epithelium inhibits proliferation and fibrogenesis by asbestos.
Christopher B Manning (2008)
Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth
D. Altomare (2005)
Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis.
B. Mossman (1990)
Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study.
L. Garland (2007)
Patterns of 8-hydroxydeoxyguanosine formation in DNA and indications of oxidative stress in rat and human pleural mesothelial cells after exposure to crocidolite asbestos.
H. Fung (1997)
Malignant mesotheliomas in a small village in the Anatolian region of Turkey: an epidemiologic study.
M. Artvinli (1979)
Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer
M. Younes (2005)
The epidermal growth factor receptor system in skin repair and inflammation.
S. Pastore (2008)
Microarray analysis and RNA silencing link fra-1 to cd44 and c-met expression in mesothelioma.
Maria E. Ramos-Nino (2003)
HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathway.
Maria E. Ramos-Nino (2008)
Mechanisms in the pathogenesis of asbestosis and silicosis.
B. Mossman (1998)
Mechanisms of fiber-induced genotoxicity.
M. Jaurand (1997)
Inhibition of protein kinase C prevents asbestos-induced c-fos and c-jun proto-oncogene expression in mesothelial cells.
H. Fung (1997)
Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression.
Maria E. Ramos-Nino (2002)
Asbestos-Induced Apoptosis Is Protein Kinase Cδ-Dependent
A. Shukla (2003)
The reactive oxygen‐driven tumor: relevance to melanoma
L. Fried (2008)
Asbestos induces nuclear factor kappa B (NF-kappa B) DNA-binding activity and NF-kappa B-dependent gene expression in tracheal epithelial cells.
Y. Janssen (1995)
Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic.
M. Cragg (2008)
Transcriptional up‐regulation of MMPs 12 and 13 by asbestos occurs via a PKCδ‐dependent pathway in murine lung
A. Shukla (2006)
Interleukin-1β and tumour necrosis factor-α promote the transformation of human immortalised mesothelial cells by erionite
Y. Wang (2004)
The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions
Seunghee Yoon (2006)
Expression of the integrin-linked kinase (ILK) in mouse skin: loss of expression in suprabasal layers of the epidermis and up-regulation by erbB-2.
W. Xie (1998)
Activation of protein kinase C by crocidolite asbestos in hamster tracheal epithelial cells.
M. Perderiset (1991)
Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer.
R. Herbst (2007)
Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium.
N. Ahmed (2006)
Reactivity of integrin-linked kinase in human mesothelial cell proliferation.
S. Watzka (2008)
Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5.
A. Boylan (1995)
Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma
D. Jackman (2008)
This paper is referenced by
Malignant Mesothelioma - ReadingSample
Andrea Tannapfel (2017)
Diana Ospina (2019)
Uncommon Nonmalignant Asbestos-Induced Conditions
S. Hammar (2011)
Asbestos and the Pathophysiology of Mesothelioma
N. Zandwijk (2019)
Medical Treatment of Mesothelioma: Anything New?
N. Takigawa (2011)
Mesothelioma risk among those exposed to chrysotile asbestos only and mixtures that include amphibole: a case–control study in the USA, 1975–1980
Jason Y Y Wong (2020)
The role of apoptosis defects in malignant mesothelioma pathogenesis with an impact on prognosis and treatment
V. Galani (2019)
Losses of Both Products of the Cdkn2a/Arf Locus Contribute to Asbestos-Induced Mesothelioma Development and Cooperate to Accelerate Tumorigenesis
D. Altomare (2011)
Protective effects of ADAM8 against cisplatin‐mediated apoptosis in non‐small‐cell lung cancer
W. Zhang (2013)
Review on toxicity of graphene following pulmonary exposure
Zara Alam (2015)
Focal amplification of HOXD-harboring chromosome region is implicated in multiple-walled carbon nanotubes-induced carcinogenicity.
Ping Wu (2013)
Clinical Year-in-Review of Occupational Lung Disease
Won-Yeon Lee (2011)
An update on pleuro‐pulmonary cytopathology: Part i: Cytological diagnosis of mesothelioma and molecular cytology of lung cancer with an historical perspective
C. Bedrossian (2015)
The emerging role of epigenetic modifiers in repair of DNA damage associated with chronic inflammatory diseases.
N. Ding (2019)
Asbestos exposure, pleural plaques, and the risk of death from lung cancer.
J. Pairon (2014)
The Impact of Nanomaterials in Immune System
Jiyoung Jang (2010)
Toxicology of high aspect ratio nanomaterials : how shape determines the biologically effective dose
Anja Schinwald (2013)
Cytochrome P450-mediated pulmonary metabolism of carcinogens: regulation and cross-talk in lung carcinogenesis.
S. Anttila (2011)
Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma
M. J. Lathrop (2014)
Molecular Investigations of the Epidermal Growth Factor Receptor and Its Affinity Toward Asbestos
E. S. Taylor (2011)
The Antioxidants Vitamins A and E and Selenium Do Not Reduce the Incidence of Asbestos-Induced Disease in a Mouse Model of Mesothelioma
C. Robinson (2012)
Pathology of lung and pleural tumours
Tim Andrews (2014)
Molecular basis of asbestos-induced lung disease.
G. Liu (2013)
Asbestos-induced tissue regeneration and malignant pleural mesothelioma: Insights from developmental studies
Emanuela Felley-Bosco (2011)
Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties.
Anja Schinwald (2012)
Annexin A4 is a possible biomarker for cisplatin susceptibility of malignant mesothelioma cells.
T. Yamashita (2012)
Analyzing biological and molecular characteristics and genomic damage induced by exposure to asbestos
D. Ospina (2019)
Hippo/YAP pathway for targeted therapy.
E. Felley-Bosco (2014)
Immunohistochemistry and molecular diagnostics of pleural malignant mesothelioma.
P. Betta (2012)
Asbestos-Induced Oxidative Stress in Lung Pathogenesis
Jill M. Miller (2014)
Chrysotile effects on the expression of anti-oncogene P53 and P16 and oncogene C-jun and C-fos in Wistar rats’ lung tissues
Y. Cui (2017)
Arsenic, asbestos and radon: emerging players in lung tumorigenesis
Roland Hubaux (2012)See more